Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Vitamin D as a Potential Therapeutic Option in Cancer Treatment: Is There a Role for Chemoprevention?

Author(s): Afsane Bahrami and Amirhossein Sahebkar*

Volume 20, Issue 18, 2020

Page: [2138 - 2149] Pages: 12

DOI: 10.2174/1871520620999200729192728

Price: $65

Abstract

Background: Vitamin D (Vit D) serves as a precursor to the potent steroid hormone calcitriol, which regulates numerous genes that control homeostasis, epithelial cell differentiation, proliferation, and apoptosis. Low level of Vit D is implicated in the development and progression of several diseases including bone fractures, cardiovascular disease, diabetes mellitus, and cancers. The present review highlights the role of vitamin D in cancer with a particular emphasis on genetic variants related to Vit D metabolism as well as clinical trials of Vit D supplementation as a potential therapeutic option in the treatment of cancer patients.

Methods: Data were collected following an electronic search in the Web of Science, Medline, PubMed, and Scopus databases by using some keywords such as “cancer”, “tumor”, “malignancy”, “vitamin D”, “cholecalciferol” and “calcitriol”.

Results: The collected evidence from the studies revealed a consistent and strong association between Vit D status and cancer risk and survival. The associations between Vit D-related genetic variants and cancer survival support the hypothesis that Vit D may affect cancer outcomes. The mechanisms whereby Vit D reduces cancer risk and increases survival are regulation of cellular differentiation, proliferation and apoptosis as well as decreased angiogenesis in tumor microenvironment and inhibition of metastasis.

Conclusion: There is a paucity of evidence-based recommendations for the optimal 25(OH)D levels in patients with cancer and the role of Vit D supplementation for primary or secondary prevention of cancer. Well-designed and sufficiently powered randomized clinical trials are necessary to assess the clinical application of Vit D in enhancing the clinical efficacy of standard and adjuvant chemotherapy regimens.

Keywords: Vitamin D, tumor, malignancy, polymorphism, VDR, chemoprevention.

« Previous Next »
Graphical Abstract

[1]
Khayyatzadeh, S.S.; Vatanparast, H.; Avan, A.; Bagherniya, M.; Bahrami, A.; Kiani, M.A.; Bahrami-Taghanaki, H.; Ferns, G.A.; Ghayour-Mobarhan, M. Serum transaminase concentrations and the presence of irritable bowel syndrome are associated with Serum 25-Hydroxy vitamin D concentrations in adolescent girls who are overweight and obese. Ann. Nutr. Metab., 2017, 71(3-4), 234-241.
[http://dx.doi.org/10.1159/000484634] [PMID: 29136622]
[2]
Tabatabaeizadeh, S.A.; Avan, A.; Bahrami, A.; Khodashenas, E.; Esmaeili, H.; Ferns, G.A.; Abdizadeh, M.F.; Ghayour-Mobarhan, M. High-dose supplementation of vitamin D affects measures of systemic inflammation: Reductions in high‐sensitivity C‐reactive protein level and Neutrophil to Lymphocyte Ratio (NLR) distribution. J. Cell. Biochem., 2017, 118(12), 4317-4322.
[http://dx.doi.org/10.1002/jcb.26084] [PMID: 28425575]
[3]
Giammanco, M.; Di Majo, D.; La Guardia, M.; Aiello, S.; Crescimannno, M.; Flandina, C.; Tumminello, F.M.; Leto, G. Vitamin D in cancer chemoprevention. Pharm. Biol., 2015, 53(10), 1399-1434.
[http://dx.doi.org/10.3109/13880209.2014.988274] [PMID: 25856702]
[4]
Nakagawa, K.; Sasaki, Y.; Kato, S.; Kubodera, N.; Okano, T. 22-Oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis, 2005, 26(6), 1044-1054.
[http://dx.doi.org/10.1093/carcin/bgi049] [PMID: 15718253]
[5]
Krishnan, A.V.; Feldman, D. Molecular pathways mediating the anti-inflammatory effects of calcitriol: Implications for prostate cancer chemoprevention and treatment. Endocr. Relat. Cancer, 2010, 17(1), R19-R38.
[http://dx.doi.org/10.1677/ERC-09-0139] [PMID: 19926709]
[6]
Zhou, W.; Suk, R.; Liu, G.; Park, S.; Neuberg, D.S.; Wain, J.C.; Lynch, T.J.; Giovannucci, E.; Christiani, D.C. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev., 2005, 14(10), 2303-2309.
[http://dx.doi.org/10.1158/1055-9965.EPI-05-0335] [PMID: 16214909]
[7]
Herbst, R.S.; Heymach, J.V.; Lippman, S.M. Lung cancer. N. Engl. J. Med., 2008, 359(13), 1367-1380.
[http://dx.doi.org/10.1056/NEJMra0802714] [PMID: 18815398]
[8]
An, B.S.; Tavera-Mendoza, L.E.; Dimitrov, V.; Wang, X.; Calderon, M.R.; Wang, H.J.; White, J.H. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol. Cell. Biol., 2010, 30(20), 4890-4900.
[http://dx.doi.org/10.1128/MCB.00180-10] [PMID: 20733005]
[9]
Haussler, M.R.; Whitfield, G.K.; Kaneko, I.; Haussler, C.A.; Hsieh, D.; Hsieh, J-C.; Jurutka, P.W. Molecular mechanisms of vitamin D action. Calcif. Tissue Int., 2013, 92(2), 77-98.
[http://dx.doi.org/10.1007/s00223-012-9619-0] [PMID: 22782502]
[10]
Sheng, L.; Anderson, P.H.; Turner, A.G.; Pishas, K.I.; Dhatrak, D.J.; Gill, P.G.; Morris, H.A.; Callen, D.F. Identification of vitamin D3 target genes in human breast cancer tissue. J. Steroid Biochem. Mol. Biol., 2016, 164, 90-97.
[http://dx.doi.org/10.1016/j.jsbmb.2015.10.012] [PMID: 26485663]
[11]
Bahrami, A.; Mazloum, S.R.; Maghsoudi, S.; Soleimani, D.; Khayyatzadeh, S.S.; Arekhi, S.; Arya, A.; Mirmoosavi, S.J.; Ferns, G.A.; Bahrami-Taghanaki, H. High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: A nine-week follow-up study. J. Diet. Suppl., 2018, 15(2), 173-182.
[PMID: 28759290]
[12]
Abbas, S.; Linseisen, J.; Rohrmann, S.; Chang-Claude, J.; Peeters, P.H.; Engel, P.; Brustad, M.; Lund, E.; Skeie, G.; Olsen, A.; Tjønneland, A.; Overvad, K.; Boutron-Ruault, M.C.; Clavel-Chapelon, F.; Fagherazzi, G.; Kaaks, R.; Boeing, H.; Buijsse, B.; Adarakis, G.; Ouranos, V.; Trichopoulou, A.; Masala, G.; Krogh, V.; Mattiello, A.; Tumino, R.; Sacerdote, C.; Buckland, G.; Suárez, M.V.; Sánchez, M.J.; Chirlaque, M.D.; Barricarte, A.; Amiano, P.; Manjer, J.; Wirfält, E.; Lenner, P.; Sund, M.; Bueno-de-Mesquita, H.B.; van Duijnhoven, F.J.; Khaw, K.T.; Wareham, N.; Key, T.J.; Fedirko, V.; Romieu, I.; Gallo, V.; Norat, T.; Wark, P.A.; Riboli, E. Dietary intake of vitamin D and calcium and breast cancer risk in the European prospective investigation into cancer and nutrition. Nutr. Cancer, 2013, 65(2), 178-187.
[http://dx.doi.org/10.1080/01635581.2013.752018] [PMID: 23441605]
[13]
Chen, P.; Li, M.; Gu, X.; Liu, Y.; Li, X.; Li, C.; Wang, Y.; Xie, D.; Wang, F.; Yu, C.; Li, J.; Chen, X.; Chu, R.; Zhu, J.; Ou, Z.; Wang, H. Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies. PLoS One, 2013, 8(1)e49312
[http://dx.doi.org/10.1371/journal.pone.0049312] [PMID: 23382798]
[14]
Shaukat, N.; Jaleel, F.; Moosa, F.A.; Qureshi, N.A. Association between vitamin D deficiency and breast cancer. Pak. J. Med. Sci., 2017, 33(3), 645-649.
[http://dx.doi.org/10.12669/pjms.333.11753] [PMID: 28811787]
[15]
Abbas, S.; Linseisen, J.; Slanger, T.; Kropp, S.; Mutschelknauss, E.J.; Flesch-Janys, D.; Chang-Claude, J. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. Carcinogenesis, 2008, 29(1), 93-99.
[http://dx.doi.org/10.1093/carcin/bgm240] [PMID: 17974532]
[16]
Colston, K.W.; Lowe, L.C.; Mansi, J.L.; Campbell, M.J. Vitamin D status and breast cancer risk. Anticancer Res., 2006, 26(4A), 2573-2580.
[PMID: 16886666]
[17]
Crew, K.D.; Gammon, M.D.; Steck, S.E.; Hershman, D.L.; Cremers, S.; Dworakowski, E.; Shane, E.; Terry, M.B.; Desai, M.; Teitelbaum, S.L.; Neugut, A.I.; Santella, R.M. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev. Res. (Phila.), 2009, 2(6), 598-604.
[http://dx.doi.org/10.1158/1940-6207.CAPR-08-0138] [PMID: 19470790]
[18]
Bertone-Johnson, E.R.; Chen, W.Y.; Holick, M.F.; Hollis, B.W.; Colditz, G.A.; Willett, W.C.; Hankinson, S.E. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 2005, 14(8), 1991-1997.
[http://dx.doi.org/10.1158/1055-9965.EPI-04-0722] [PMID: 16103450]
[19]
Mohr, S.B.; Gorham, E.D.; Alcaraz, J.E.; Kane, C.I.; Macera, C.A.; Parsons, J.K.; Wingard, D.L.; Horst, R.; Garland, C.F. Serum 25-hydroxyvitamin D and breast cancer in the military: A case-control study utilizing pre-diagnostic serum. Cancer Causes Control, 2013, 24(3), 495-504.
[http://dx.doi.org/10.1007/s10552-012-0140-6] [PMID: 23296455]
[20]
Engel, P.; Fagherazzi, G.; Boutten, A.; Dupré, T.; Mesrine, S.; Boutron-Ruault, M-C.; Clavel-Chapelon, F. Serum 25(OH) vitamin D and risk of breast cancer: A nested case-control study from the French E3N cohort. Cancer Epidemiol. Biomarkers Prev., 2010, 19(9), 2341-2350.
[http://dx.doi.org/10.1158/1055-9965.EPI-10-0264] [PMID: 20826834]
[21]
Scarmo, S.; Afanasyeva, Y.; Lenner, P.; Koenig, K.L.; Horst, R.L.; Clendenen, T.V.; Arslan, A.A.; Chen, Y.; Hallmans, G.; Lundin, E.; Rinaldi, S.; Toniolo, P.; Shore, R.E.; Zeleniuch-Jacquotte, A. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: A nested case-control study. Breast Cancer Res., 2013, 15(1), R15.
[http://dx.doi.org/10.1186/bcr3390] [PMID: 23442740]
[22]
Amir, E.; Cecchini, R.S.; Ganz, P.A.; Costantino, J.P.; Beddows, S.; Hood, N.; Goodwin, P.J. 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res. Treat., 2012, 133(3), 1077-1088.
[http://dx.doi.org/10.1007/s10549-012-2012-x] [PMID: 22415479]
[23]
Skaaby, T.; Husemoen, L.L.N.; Thuesen, B.H.; Pisinger, C.; Jørgensen, T.; Roswall, N.; Larsen, S.C.; Linneberg, A. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol. Biomarkers Prev., 2014, 23(7)
[24]
Ismail, A.; El-Awady, R.; Mohamed, G.; Hussein, M.; Ramadan, S.S. Prognostic significance of serum vitamin D levels in Egyptian females with breast cancer. Asian Pac. J. Cancer Prev., 2018, 19(2), 571-576.
[PMID: 29481024]
[25]
Garland, C.F.; Gorham, E.D.; Mohr, S.B.; Grant, W.B.; Giovannucci, E.L.; Lipkin, M.; Newmark, H.; Holick, M.F.; Garland, F.C. Vitamin D and prevention of breast cancer: Pooled analysis. J. Steroid Biochem. Mol. Biol., 2007, 103(3-5), 708-711.
[http://dx.doi.org/10.1016/j.jsbmb.2006.12.007] [PMID: 17368188]
[26]
O’Brien, K.M.; Sandler, D.P.; Taylor, J.A.; Weinberg, C.R. Serum vitamin D and risk of breast cancer within five years. Environ. Health Perspect., 2017, 125(7)077004
[http://dx.doi.org/10.1289/EHP943] [PMID: 28728134]
[27]
Bauer, S.R.; Hankinson, S.E.; Bertone-Johnson, E.R.; Ding, E.L. Plasma vitamin D levels, menopause, and risk of breast cancer: Dose-response meta-analysis of prospective studies. Medicine (Baltimore), 2013, 92(3), 123-131.
[http://dx.doi.org/10.1097/MD.0b013e3182943bc2] [PMID: 23625163]
[28]
Estebanez, N.; Gomez-Acebo, I. Vitamin D exposure and Risk of Breast Cancer: a meta-analysis. Sci. Rep., 2018, 8(1), 9039.
[http://dx.doi.org/10.1038/s41598-018-27297-1]
[29]
Ameri, P.; Giusti, A.; Boschetti, M.; Murialdo, G.; Minuto, F.; Ferone, D. Interactions between vitamin D and IGF-I: From physiology to clinical practice. Clin. Endocrinol. (Oxf.), 2013, 79(4), 457-463.
[http://dx.doi.org/10.1111/cen.12268] [PMID: 23789983]
[30]
Gómez, J.M. The role of insulin-like growth factor I components in the regulation of vitamin D. Curr. Pharm. Biotechnol., 2006, 7(2), 125-132.
[http://dx.doi.org/10.2174/138920106776597621] [PMID: 16724947]
[31]
Chlebowski, R.T. Vitamin D and breast cancer: Interpreting current evidence. Breast Cancer Res., 2011, 13(4), 217.
[http://dx.doi.org/10.1186/bcr2846] [PMID: 21884640]
[32]
Mawer, E.B.; Walls, J.; Howell, A.; Davies, M.; Ratcliffe, W.A.; Bundred, N.J. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J. Clin. Endocrinol. Metab., 1997, 82(1), 118-122.
[http://dx.doi.org/10.1210/jc.82.1.118] [PMID: 8989244]
[33]
Hossain, S.; Beydoun, M.A.; Beydoun, H.A.; Chen, X.; Zonderman, A.B.; Wood, R.J. Vitamin D and breast cancer: A systematic review and meta-analysis of observational studies. Clin. Nutr. ESPEN, 2019, 30, 170-184.
[http://dx.doi.org/10.1016/j.clnesp.2018.12.085] [PMID: 30904218]
[34]
Lappe, J.M.; Travers-Gustafson, D.; Davies, K.M.; Recker, R.R.; Heaney, R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr., 2007, 85(6), 1586-1591.
[http://dx.doi.org/10.1093/ajcn/85.6.1586] [PMID: 17556697]
[35]
Walentowicz-Sadlecka, M.; Grabiec, M.; Sadlecki, P.; Gotowska, M.; Walentowicz, P.; Krintus, M.; Mankowska-Cyl, A.; Sypniewska, G. 25(OH)D3 in patients with ovarian cancer and its correlation with survival. Clin. Biochem., 2012, 45(18), 1568-1572.
[http://dx.doi.org/10.1016/j.clinbiochem.2012.07.110] [PMID: 22884489]
[36]
Goodwin, P.J.; Ennis, M.; Pritchard, K.I.; Koo, J.; Hood, N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J. Clin. Oncol., 2009, 27(23), 3757-3763.
[http://dx.doi.org/10.1200/JCO.2008.20.0725] [PMID: 19451439]
[37]
Vrieling, A.; Hein, R.; Abbas, S.; Schneeweiss, A.; Flesch-Janys, D.; Chang-Claude, J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res., 2011, 13(4), R74.
[http://dx.doi.org/10.1186/bcr2920] [PMID: 21791049]
[38]
Hu, K.; Callen, D.F.; Li, J.; Zheng, H. Circulating vitamin D and overall survival in breast cancer patients: A dose-response meta-analysis of cohort studies. Integr. Cancer Ther., 2018, 17(2), 217-225.
[http://dx.doi.org/10.1177/1534735417712007] [PMID: 28589744]
[39]
Li, M.; Chen, P.; Li, J.; Chu, R.; Xie, D.; Wang, H. Review: The impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab., 2014, 99(7), 2327-2336.
[http://dx.doi.org/10.1210/jc.2013-4320] [PMID: 24780061]
[40]
Villaseñor, A.; Ballard-Barbash, R.; Ambs, A.; Bernstein, L.; Baumgartner, K.; Baumgartner, R.; Ulrich, C.M.; Hollis, B.W.; McTiernan, A.; Neuhouser, M.L. Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control, 2013, 24(4), 759-767.
[http://dx.doi.org/10.1007/s10552-013-0158-4] [PMID: 23361338]
[41]
Garland, C.F.; Gorham, E.D.; Mohr, S.B.; Garland, F.C. Vitamin D for cancer prevention: Global perspective. Ann. Epidemiol., 2009, 19(7), 468-483.
[http://dx.doi.org/10.1016/j.annepidem.2009.03.021] [PMID: 19523595]
[42]
Krishnan, A.V.; Swami, S.; Peng, L.; Wang, J.; Moreno, J.; Feldman, D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology, 2010, 151(1), 32-42.
[http://dx.doi.org/10.1210/en.2009-0855] [PMID: 19906814]
[43]
Swami, S.; Krishnan, A.V.; Peng, L.; Lundqvist, J.; Feldman, D. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements. Endocr. Relat. Cancer, 2013, 20(4), 565-577.
[http://dx.doi.org/10.1530/ERC-12-0281] [PMID: 23744764]
[44]
Santos-Martínez, N.; Díaz, L.; Ordaz-Rosado, D.; García-Quiroz, J.; Barrera, D.; Avila, E.; Halhali, A.; Medina-Franco, H.; Ibarra-Sánchez, M.J.; Esparza-López, J.; Camacho, J.; Larrea, F.; García-Becerra, R. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach. BMC Cancer, 2014, 14, 230.
[http://dx.doi.org/10.1186/1471-2407-14-230] [PMID: 24678876]
[45]
Williams, J.D.; Aggarwal, A.; Swami, S.; Krishnan, A.V.; Ji, L.; Albertelli, M.A.; Feldman, B.J. Tumor autonomous effects of vitamin D deficiency promote breast cancer metastasis. Endocrinology, 2016, 157(4), 1341-1347.
[http://dx.doi.org/10.1210/en.2015-2036] [PMID: 26934299]
[46]
Binabaj, M.M.; Bahrami, A. ShahidSales, S.; Joodi, M.; Joudi Mashhad, M.; Hassanian, S.M.; Anvari, K.; Avan, A. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials. J. Cell. Physiol., 2018, 233(1), 378-386.
[http://dx.doi.org/10.1002/jcp.25896] [PMID: 28266716]
[47]
Fernandez-Garcia, N.I.; Palmer, H.G.; Garcia, M.; Gonzalez-Martin, A.; del Rio, M.; Barettino, D.; Volpert, O.; Muñoz, A.; Jimenez, B. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene, 2005, 24(43), 6533-6544.
[http://dx.doi.org/10.1038/sj.onc.1208801] [PMID: 16007183]
[48]
Iseki, K.; Tatsuta, M.; Uehara, H.; Iishi, H.; Yano, H.; Sakai, N.; Ishiguro, S. Inhibition of angiogenesis as a mechanism for inhibition by 1alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int. J. Cancer, 1999, 81(5), 730-733.
[http://dx.doi.org/10.1002/(SICI)1097-0215(19990531)81:5<730:AID-IJC11>3.0.CO;2-Q] [PMID: 10328225]
[49]
Ben-Shoshan, M.; Amir, S.; Dang, D.T.; Dang, L.H.; Weisman, Y.; Mabjeesh, N.J. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol. Cancer Ther., 2007, 6(4), 1433-1439.
[http://dx.doi.org/10.1158/1535-7163.MCT-06-0677] [PMID: 17431122]
[50]
Andersen, S.W.; Shu, X-O.; Cai, Q.; Khankari, N.K.; Steinwandel, M.D.; Jurutka, P.W.; Blot, W.J.; Zheng, W. Total and free circulating vitamin D and vitamin D binding protein in relation to colorectal cancer risk in a prospective study of African Americans. Cancer Epidemiol. Biomarkers Prev., 2017, 26(8)
[http://dx.doi.org/10.1158/1055-9965.EPI-17-0133]
[51]
Facciorusso, A.; Del Prete, V.; Muscatiello, N.; Crucinio, N.; Barone, M. Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation. J. Gastroenterol. Hepatol., 2016, 31(8), 1483-1488.
[http://dx.doi.org/10.1111/jgh.13326] [PMID: 26896637]
[52]
Obermannova, R.; Dusek, L.; Greplova, K.; Jarkovsky, J.; Sterba, J.; Vyzula, R.; Demlova, R.; Zdrazilova-Dubska, L.; Valik, D. Time-course pattern of blood 25-hydroxycholecalciferol is a significant predictor of survival outcome in metastatic colorectal cancer: a clinical practice-based study. Neoplasma, 2015, 62(6), 958-965.
[http://dx.doi.org/10.4149/neo_2015_116] [PMID: 26458311]
[53]
Chen, B.; Zhang, D.P.; Gao, W. Effect of curcumin on the expression of collagen type I protein and transforming growth factor-beta1 mRNA in pulmonary fibrosis rats. Ch. J. Indust. Hyg. Occup. Dis., 2008, 26(5), 257-261.
[54]
Ng, K.; Venook, A.P.; Sato, K.; Yuan, C.; Hollis, B.W.; Niedzwiecki, D.; Ye, C.; Chang, I-W.; O’Neil, B.H.; Innocenti, F. Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance). J. Clin. Oncol., 2015, 33(15), 3503.
[55]
Fedirko, V.; Riboli, E.; Tjønneland, A.; Ferrari, P.; Olsen, A.; Bueno-de-Mesquita, H.B.; van Duijnhoven, F.J.; Norat, T.; Jansen, E.H.; Dahm, C.C.; Overvad, K.; Boutron-Ruault, M.C.; Clavel-Chapelon, F.; Racine, A.; Lukanova, A.; Teucher, B.; Boeing, H.; Aleksandrova, K.; Trichopoulou, A.; Benetou, V.; Trichopoulos, D.; Grioni, S.; Vineis, P.; Panico, S.; Palli, D.; Tumino, R.; Siersema, P.D.; Peeters, P.H.; Skeie, G.; Brustad, M.; Chirlaque, M.D.; Barricarte, A.; Ramón Quirós, J.; Sánchez, M.J.; Dorronsoro, M.; Bonet, C.; Palmqvist, R.; Hallmans, G.; Key, T.J.; Crowe, F.; Khaw, K.T.; Wareham, N.; Romieu, I.; McKay, J.; Wark, P.A.; Romaguera, D.; Jenab, M. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol. Biomarkers Prev., 2012, 21(4), 582-593.
[http://dx.doi.org/10.1158/1055-9965.EPI-11-1065] [PMID: 22278364]
[56]
Song, M.; Konijeti, G.G.; Yuan, C.; Ananthakrishnan, A.N.; Ogino, S.; Fuchs, C.S.; Giovannucci, E.; Ng, K.; Chan, A.T. Plasma 25-hydroxyvitamin D, vitamin D binding protein, and risk of colorectal cancer in the nurses’ health study. Cancer Prev. Res., 2016, 9(8), 664-672.
[57]
Cooney, R.V.; Chai, W.; Franke, A.A.; Wilkens, L.R.; Kolonel, L.N.; Le Marchand, L. C-reactive protein, lipid-soluble micronutrients, and survival in colorectal cancer patients. Cancer Epidemiol. Prev. Biomarkers, 2013, 22(7), 1278-1288.
[58]
Zgaga, L.; Theodoratou, E.; Farrington, S.M.; Din, F.V.; Ooi, L.Y.; Glodzik, D.; Johnston, S.; Tenesa, A.; Campbell, H.; Dunlop, M.G. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J. Clin. Oncol., 2014, 32(23), 2430-2439.
[http://dx.doi.org/10.1200/JCO.2013.54.5947] [PMID: 25002714]
[59]
Maalmi, H.; Walter, V.; Jansen, L.; Chang-Claude, J.; Owen, R.W.; Ulrich, A.; Schöttker, B.; Hoffmeister, M.; Brenner, H. Relationship of very low serum 25-hydroxyvitamin D3 levels with long-term survival in a large cohort of colorectal cancer patients from Germany. Eur. J. Epidemiol., 2017, 32(11), 961-971.
[http://dx.doi.org/10.1007/s10654-017-0298-z] [PMID: 28884317]
[60]
Boscoe, F.P.; Schymura, M.J. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer, 2006, 6(1), 264.
[http://dx.doi.org/10.1186/1471-2407-6-264] [PMID: 17096841]
[61]
Chen, W.; Clements, M.; Rahman, B.; Zhang, S.; Qiao, Y.; Armstrong, B.K. Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control, 2010, 21(10), 1701-1709.
[http://dx.doi.org/10.1007/s10552-010-9599-1] [PMID: 20552265]
[62]
Mizoue, T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys., 2004, 87(5), 532-538.
[http://dx.doi.org/10.1097/01.HP.0000137179.03423.0b] [PMID: 15551791]
[63]
Tretli, S.; Schwartz, G.G.; Torjesen, P.A.; Robsahm, T.E. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: A population-based study. Cancer Causes Control, 2012, 23(2), 363-370.
[http://dx.doi.org/10.1007/s10552-011-9885-6] [PMID: 22193397]
[64]
Yang, B.; McCullough, M.L.; Gapstur, S.M.; Jacobs, E.J.; Bostick, R.M.; Fedirko, V.; Flanders, W.D.; Campbell, P.T. Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: the Cancer Prevention Study-II Nutrition Cohort. J. Clin. Oncol., 2014, 32(22), 2335-2343.
[http://dx.doi.org/10.1200/JCO.2014.55.3024] [PMID: 24958826]
[65]
Giessen-Jung, C.; Nagel, D.; Glas, M.; Spelsberg, F.; Lau-Werner, U.; Modest, D.P.; Schulz, C.; Heinemann, V.; Di Gioia, D.; Stieber, P. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer. Tumour Biol., 2015, 36(10), 7897-7906.
[http://dx.doi.org/10.1007/s13277-015-3522-z] [PMID: 25953265]
[66]
Weinstein, S.J.; Yu, K.; Horst, R.L.; Ashby, J.; Virtamo, J.; Albanes, D. Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men. Am. J. Epidemiol., 2011, 173(5), 499-508.
[http://dx.doi.org/10.1093/aje/kwq398] [PMID: 21248311]
[67]
Anic, G.M.; Weinstein, S.J.; Mondul, A.M.; Männistö, S.; Albanes, D. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One, 2014, 9(7)e102966
[http://dx.doi.org/10.1371/journal.pone.0102966] [PMID: 25036524]
[68]
McCullough, M.L.; Zoltick, E.S.; Weinstein, S.J.; Fedirko, V.; Wang, M.; Cook, N.R.; Eliassen, A.H.; Zeleniuch-Jacquotte, A.; Agnoli, C.; Albanes, D.; Barnett, M.J.; Buring, J.E.; Campbell, P.T.; Clendenen, T.V.; Freedman, N.D.; Gapstur, S.M.; Giovannucci, E.L.; Goodman, G.G.; Haiman, C.A.; Ho, G.Y.F.; Horst, R.L.; Hou, T.; Huang, W.Y.; Jenab, M.; Jones, M.E.; Joshu, C.E.; Krogh, V.; Lee, I.M.; Lee, J.E.; Männistö, S.; Le Marchand, L.; Mondul, A.M.; Neuhouser, M.L.; Platz, E.A.; Purdue, M.P.; Riboli, E.; Robsahm, T.E.; Rohan, T.E.; Sasazuki, S.; Schoemaker, M.J.; Sieri, S.; Stampfer, M.J.; Swerdlow, A.J.; Thomson, C.A.; Tretli, S.; Tsugane, S.; Ursin, G.; Visvanathan, K.; White, K.K.; Wu, K.; Yaun, S.S.; Zhang, X.; Willett, W.C.; Gail, M.H.; Ziegler, R.G.; Smith-Warner, S.A. Circulating vitamin D and colorectal cancer risk: An international pooling project of 17 cohorts. J. Natl. Cancer Inst., 2019, 111(2), 158-169.
[http://dx.doi.org/10.1093/jnci/djy087] [PMID: 29912394]
[69]
Keum, N.; Greenwood, D.C.; Lee, D.H.; Kim, R.; Aune, D.; Ju, W.; Hu, F.B.; Giovannucci, E.L. Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies. J. Natl. Cancer Inst., 2015, 107(2)djv088
[http://dx.doi.org/10.1093/jnci/djv088] [PMID: 25757865]
[70]
Garcia-Albeniz, X.; Rudolph, A.; Hutter, C.; White, E.; Lin, Y.; Rosse, S.A.; Figueiredo, J.C.; Harrison, T.A.; Jiao, S.; Brenner, H.; Casey, G.; Hudson, T.J.; Thornquist, M.; Le Marchand, L.; Potter, J.; Slattery, M.L.; Zanke, B.; Baron, J.A.; Caan, B.J.; Chanock, S.J.; Berndt, S.I.; Stelling, D.; Fuchs, C.S.; Hoffmeister, M.; Butterbach, K.; Du, M.; James Gauderman, W.; Gunter, M.J.; Lemire, M.; Ogino, S.; Lin, J.; Hayes, R.B.; Haile, R.W.; Schoen, R.E.; Warnick, G.S.; Jenkins, M.A.; Thibodeau, S.N.; Schumacher, F.R.; Lindor, N.M.; Kolonel, L.N.; Hopper, J.L.; Gong, J.; Seminara, D.; Pflugeisen, B.M.; Ulrich, C.M.; Qu, C.; Duggan, D.; Cotterchio, M.; Campbell, P.T.; Carlson, C.S.; Newcomb, P.A.; Giovannucci, E.; Hsu, L.; Chan, A.T.; Peters, U.; Chang-Claude, J. CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br. J. Cancer, 2016, 114(2), 221-229.
[http://dx.doi.org/10.1038/bjc.2015.443] [PMID: 26766742]
[71]
Ding, E.L.; Mehta, S.; Fawzi, W.W.; Giovannucci, E.L. Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: Reanalysis of Women’s Health Initiative randomized trial. Int. J. Cancer, 2008, 122(8), 1690-1694.
[http://dx.doi.org/10.1002/ijc.23311] [PMID: 18092326]
[72]
Ekmekcioglu, C.; Haluza, D.; Kundi, M. 25-Hydroxyvitamin D status and risk for colorectal cancer and Type 2 Diabetes Mellitus: A systematic review and meta-analysis of epidemiological studies. Int. J. Environ. Res. Public Health, 2017, 14(2), 127.
[http://dx.doi.org/10.3390/ijerph14020127] [PMID: 28134804]
[73]
Kottler, M-L. Is vitamin D a key factor in muscle health? Endocrinology, 2013, 154(11), 3963-3964.
[http://dx.doi.org/10.1210/en.2013-1881]
[74]
Paul, C.L.; Cameron, E.; Doran, C.; Hill, D.; Macrae, F.; Carey, M.L.; Sanson-Fisher, R.W. Experiences of colorectal cancer patients in the 2-years post-diagnosis and patient factors predicting poor outcome. Support. Care Cancer, 2016, 24(12), 4921-4928.
[http://dx.doi.org/10.1007/s00520-016-3348-2] [PMID: 27422656]
[75]
Blauwhoff-Buskermolen, S.; Versteeg, K.S. de van der Schueren, M.A.; den Braver, N.R.; Berkhof, J.; Langius, J.A.; Verheul, H.M.; de van der Schueren, M.A.; Den Braver, N.R.; Berkhof, J.; Langius, J.A.; Verheul, H.M. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J. Clin. Oncol., 2016, 34(12), 1339-1344.
[http://dx.doi.org/10.1200/JCO.2015.63.6043] [PMID: 26903572]
[76]
Bessler, H.; Djaldetti, M. 1alpha,25-Dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells. Biomed. Pharmacother., 2012, 66(6), 428-432.
[77]
Bahrami, A.; Khazaei, M.; Bagherieh, F.; GhayouráMobarhan, M.; Maftouh, M.; Hassanian, S.M.; Avan, A. Targeted stroma in pancreatic cancer: Promises and failures of target therapies. J. Cell. Physiol., 2017, 232(11), 2931-2937.
[http://dx.doi.org/10.1002/jcp.25798]
[78]
Mathieu, C.; Gysemans, C.; Giulietti, A.; Bouillon, R. Vitamin D and diabetes. Diabetologia, 2005, 48(7), 1247-1257.
[http://dx.doi.org/10.1007/s00125-005-1802-7] [PMID: 15971062]
[79]
Maestro, B.; Molero, S.; Bajo, S.; Dávila, N.; Calle, C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem. Funct., 2002, 20(3), 227-232.
[http://dx.doi.org/10.1002/cbf.951] [PMID: 12125099]
[80]
Cho, M.; Peddi, P.F.; Ding, K.; Chen, L.; Thomas, D.; Wang, J.; Lockhart, A.C.; Tan, B.; Wang-Gillam, A. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. J. Transl. Med., 2013, 11(1), 206.
[http://dx.doi.org/10.1186/1479-5876-11-206] [PMID: 24011168]
[81]
Yuan, C.; Qian, Z.R.; Babic, A.; Morales-Oyarvide, V.; Rubinson, D.A.; Kraft, P.; Ng, K.; Bao, Y.; Giovannucci, E.L.; Ogino, S.; Stampfer, M.J.; Gaziano, J.M.; Sesso, H.D.; Buring, J.E.; Cochrane, B.B.; Chlebowski, R.T.; Snetselaar, L.G.; Manson, J.E.; Fuchs, C.S.; Wolpin, B.M. Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival. J. Clin. Oncol., 2016, 34(24), 2899-2905.
[http://dx.doi.org/10.1200/JCO.2015.66.3005] [PMID: 27325858]
[82]
Zhu, X.; Song, X.; Xie, K.; Zhang, X.; He, W.; Liu, F. Osthole induces apoptosis and suppresses proliferation via the PI3K/Akt pathway in intrahepatic cholangiocarcinoma. Int. J. Mol. Med., 2017, 40(4), 1143-1151.
[http://dx.doi.org/10.3892/ijmm.2017.3113] [PMID: 28902342]
[83]
van Duijnhoven, F.J.B.; Jenab, M.; Hveem, K.; Siersema, P.D.; Fedirko, V.; Duell, E.J. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Int. J. Cancer, 2018, 142(6), 1189-1201.
[http://dx.doi.org/10.1002/ijc.31146]
[84]
Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr., 2004, 80(6)(Suppl.), 1678S-1688S.
[http://dx.doi.org/10.1093/ajcn/80.6.1678S] [PMID: 15585788]
[85]
Bao, A.; Li, Y.; Tong, Y.; Zheng, H.; Wu, W.; Wei, C. 1,25-Dihydroxyvitamin Dá and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells. Int. J. Mol. Med., 2014, 33(5), 1177-1184.
[http://dx.doi.org/10.3892/ijmm.2014.1664] [PMID: 24573222]
[86]
Wang, W.; Zhao, C-H.; Zhang, N.; Wang, J. Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway. Nutr. Cancer, 2013, 65(7), 1067-1075.
[http://dx.doi.org/10.1080/01635581.2013.811273] [PMID: 24099173]
[87]
Ren, C.; Qiu, M.Z.; Wang, D.S.; Luo, H.Y.; Zhang, D.S.; Wang, Z.Q.; Wang, F.H.; Li, Y.H.; Zhou, Z.W.; Xu, R.H. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J. Transl. Med., 2012, 10(1), 16.
[http://dx.doi.org/10.1186/1479-5876-10-16] [PMID: 22284859]
[88]
Vyas, N.; Companioni, R.C.; Tiba, M.; Alkhawam, H.; Catalano, C.; Sogomonian, R.; Baum, J.; Walfish, A. Association between serum vitamin D levels and gastric cancer: A retrospective chart analysis. World J. Gastrointest. Oncol., 2016, 8(9), 688-694.
[http://dx.doi.org/10.4251/wjgo.v8.i9.688] [PMID: 27672427]
[89]
Fanidi, A.; Muller, D.C.; Midttun, Ø.; Ueland, P.M.; Vollset, S.E.; Relton, C.; Vineis, P.; Weiderpass, E.; Skeie, G.; Brustad, M.; Palli, D.; Tumino, R.; Grioni, S.; Sacerdote, C.; Bueno-de-Mesquita, H.B.; Peeters, P.H.; Boutron-Ruault, M.C.; Kvaskoff, M.; Cadeau, C.; Huerta, J.M.; Sánchez, M.J.; Agudo, A.; Lasheras, C.; Quirós, J.R.; Chamosa, S.; Riboli, E.; Travis, R.C.; Ward, H.; Murphy, N.; Khaw, K.T.; Trichopoulou, A.; Lagiou, P.; Papatesta, E.M.; Boeing, H.; Kuehn, T.; Katzke, V.; Steffen, A.; Johansson, A.; Brennan, P.; Johansson, M. Circulating vitamin D in relation to cancer incidence and survival of the head and neck and oesophagus in the EPIC cohort. Sci. Rep., 2016, 6, 36017.
[http://dx.doi.org/10.1038/srep36017] [PMID: 27812016]
[90]
Zgaga, L.; O’Sullivan, F.; Cantwell, M.M.; Murray, L.J.; Thota, P.N.; Coleman, H.G. Markers of vitamin D exposure and esophageal cancer risk: A systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev., 2016, 25(6), 877-886.
[http://dx.doi.org/10.1158/1055-9965.EPI-15-1162] [PMID: 27030602]
[91]
Wu, X.; Cheng, J.; Yang, K. Vitamin D-related gene polymorphisms, plasma 25-Hydroxy-vitamin D, cigarette smoke and Non-Small Cell Lung Cancer (NSCLC). Risk. Int. J. Mol. Sci., 2016, 17(10), 1597.
[http://dx.doi.org/10.3390/ijms17101597] [PMID: 27669215]
[92]
Zhang, L.; Wang, S.; Che, X.; Li, X. Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell. Physiol. Biochem., 2015, 36(1), 299-305.
[http://dx.doi.org/10.1159/000374072] [PMID: 25967968]
[93]
Chen, G-C.; Zhang, Z-L.; Wan, Z.; Wang, L.; Weber, P.; Eggersdorfer, M.; Qin, L-Q.; Zhang, W. Circulating 25-hydroxyvitamin D and risk of lung cancer: A dose-response meta-analysis. Cancer Causes Control, 2015, 26(12), 1719-1728.
[http://dx.doi.org/10.1007/s10552-015-0665-6] [PMID: 26358829]
[94]
Liu, J.; Dong, Y.; Lu, C.; Wang, Y.; Peng, L.; Jiang, M.; Tang, Y.; Zhao, Q. Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes. Oncotarget, 2017, 8(46), 81040-81051.
[http://dx.doi.org/10.18632/oncotarget.18766] [PMID: 29113365]
[95]
Gilbert, R.; Martin, R.M.; Beynon, R.; Harris, R.; Savovic, J.; Zuccolo, L.; Bekkering, G.E.; Fraser, W.D.; Sterne, J.A.; Metcalfe, C. Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis. Cancer Causes Control, 2011, 22(3), 319-340.
[http://dx.doi.org/10.1007/s10552-010-9706-3] [PMID: 21203822]
[96]
Shui, I.M.; Mucci, L.A.; Kraft, P.; Tamimi, R.M.; Lindstrom, S.; Penney, K.L.; Nimptsch, K.; Hollis, B.W.; Dupre, N.; Platz, E.A.; Stampfer, M.J.; Giovannucci, E. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: A prospective nested case-control study. J. Natl. Cancer Inst., 2012, 104(9), 690-699.
[http://dx.doi.org/10.1093/jnci/djs189] [PMID: 22499501]
[97]
Gilbert, R.; Metcalfe, C.; Fraser, W.D.; Donovan, J.; Hamdy, F.; Neal, D.E.; Lane, J.A.; Martin, R.M. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade. Int. J. Cancer, 2012, 131(5), 1187-1196.
[http://dx.doi.org/10.1002/ijc.27327] [PMID: 22033893]
[98]
Nelson, S.M.; Batai, K.; Ahaghotu, C.; Agurs-Collins, T.; Kittles, R.A. Association between serum 25-hydroxy-vitamin D and aggressive prostate cancer in African American men. Nutrients, 2016, 9(1), 12.
[http://dx.doi.org/10.3390/nu9010012] [PMID: 28036013]
[99]
Xu, Y.; Shao, X.; Yao, Y.; Xu, L.; Chang, L.; Jiang, Z.; Lin, Z. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: New findings from an updated meta-analysis. J. Cancer Res. Clin. Oncol., 2014, 140(9), 1465-1477.
[http://dx.doi.org/10.1007/s00432-014-1706-3] [PMID: 24838848]
[100]
Tuohimaa, P.; Tenkanen, L.; Ahonen, M.; Lumme, S.; Jellum, E.; Hallmans, G.; Stattin, P.; Harvei, S.; Hakulinen, T.; Luostarinen, T.; Dillner, J.; Lehtinen, M.; Hakama, M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer, 2004, 108(1), 104-108.
[http://dx.doi.org/10.1002/ijc.11375] [PMID: 14618623]
[101]
Rowland, G.W.; Schwartz, G.G.; John, E.M.; Ingles, S.A. Calcium intake and prostate cancer among African Americans: Effect modification by vitamin D receptor calcium absorption genotype. J. Bone Miner. Res., 2012, 27(1), 187-194.
[http://dx.doi.org/10.1002/jbmr.505]
[102]
Yin, L.; Grandi, N.; Raum, E.; Haug, U.; Arndt, V.; Brenner, H. Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol. Oncol., 2011, 121(2), 369-375.
[http://dx.doi.org/10.1016/j.ygyno.2011.01.023] [PMID: 21324518]
[103]
Zheng, W.; Danforth, K.N.; Tworoger, S.S.; Goodman, M.T.; Arslan, A.A.; Patel, A.V.; McCullough, M.L.; Weinstein, S.J.; Kolonel, L.N.; Purdue, M.P.; Shu, X.O.; Snyder, K.; Steplowski, E.; Visvanathan, K.; Yu, K.; Zeleniuch-Jacquotte, A.; Gao, Y.T.; Hankinson, S.E.; Harvey, C.; Hayes, R.B.; Henderson, B.E.; Horst, R.L.; Helzlsouer, K.J. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort consortium vitamin D pooling project of rarer cancers. Am. J. Epidemiol., 2010, 172(1), 70-80.
[http://dx.doi.org/10.1093/aje/kwq118] [PMID: 20562186]
[104]
Qin, B.; Moorman, P.G.; Alberg, A.J.; Barnholtz-Sloan, J.S.; Bondy, M.; Cote, M.L.; Funkhouser, E.; Peters, E.S.; Schwartz, A.G.; Terry, P.; Schildkraut, J.M.; Bandera, E.V. Dairy, calcium, vitamin D and ovarian cancer risk in African-American women. Br. J. Cancer, 2016, 115(9), 1122-1130.
[http://dx.doi.org/10.1038/bjc.2016.289] [PMID: 27632371]
[105]
Ong, J-S.; Cuellar-Partida, G.; Lu, Y.; Fasching, P.A.; Hein, A.; Burghaus, S.; Beckmann, M.W.; Lambrechts, D.; Van Nieuwenhuysen, E.; Vergote, I.; Vanderstichele, A.; Anne Doherty, J.; Anne Rossing, M.; Chang-Claude, J.; Eilber, U.; Rudolph, A.; Wang-Gohrke, S.; Goodman, M.T.; Bogdanova, N.; Dörk, T.; Dürst, M.; Hillemanns, P.; Runnebaum, I.B.; Antonenkova, N.; Butzow, R.; Leminen, A.; Nevanlinna, H.; Pelttari, L.M.; Edwards, R.P.; Kelley, J.L.; Modugno, F.; Moysich, K.B.; Ness, R.B.; Cannioto, R.; Høgdall, E.; Høgdall, C.K.; Jensen, A.; Giles, G.G.; Bruinsma, F.; Kjaer, S.K.; Hildebrandt, M.A.; Liang, D.; Lu, K.H.; Wu, X.; Bisogna, M.; Dao, F.; Levine, D.A.; Cramer, D.W.; Terry, K.L.; Tworoger, S.S.; Stampfer, M.; Missmer, S.; Bjorge, L.; Salvesen, H.B.; Kopperud, R.K.; Bischof, K.; Aben, K.K.; Kiemeney, L.A.; Massuger, L.F.; Brooks-Wilson, A.; Olson, S.H.; McGuire, V.; Rothstein, J.H.; Sieh, W.; Whittemore, A.S.; Cook, L.S.; Le, N.D.; Gilks, C.B.; Gronwald, J.; Jakubowska, A.; Lubiński, J.; Kluz, T.; Song, H.; Tyrer, J.P.; Wentzensen, N.; Brinton, L.; Trabert, B.; Lissowska, J.; McLaughlin, J.R.; Narod, S.A.; Phelan, C.; Anton-Culver, H.; Ziogas, A.; Eccles, D.; Campbell, I.; Gayther, S.A.; Gentry-Maharaj, A.; Menon, U.; Ramus, S.J.; Wu, A.H.; Dansonka-Mieszkowska, A.; Kupryjanczyk, J.; Timorek, A.; Szafron, L.; Cunningham, J.M.; Fridley, B.L.; Winham, S.J.; Bandera, E.V.; Poole, E.M.; Morgan, T.K.; Risch, H.A.; Goode, E.L.; Schildkraut, J.M.; Pearce, C.L.; Berchuck, A.; Pharoah, P.D.; Chenevix-Trench, G.; Gharahkhani, P.; Neale, R.E.; Webb, P.M.; MacGregor, S. Australian Ovarian Cancer Study. Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study. Int. J. Epidemiol., 2016, 45(5), 1619-1630.
[http://dx.doi.org/10.1093/ije/dyw207] [PMID: 27594614]
[106]
Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, 136(5), E359-E386.
[http://dx.doi.org/10.1002/ijc.29210] [PMID: 25220842]
[107]
Morice, P.; Leary, A.; Creutzberg, C.; Abu-Rustum, N.; Darai, E. Endometrial cancer. Lancet, 2016, 387(10023), 1094-1108.
[http://dx.doi.org/10.1016/S0140-6736(15)00130-0] [PMID: 26354523]
[108]
Ahonen, M.H.; Zhuang, Y.H.; Aine, R.; Ylikomi, T.; Tuohimaa, P. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int. J. Cancer, 2000, 86(1), 40-46.
[http://dx.doi.org/10.1002/(SICI)1097-0215(20000401)86:1<40:AID-IJC6>3.0.CO;2-E] [PMID: 10728592]
[109]
Jiang, F.; Li, P.; Fornace, A.J., Jr; Nicosia, S.V.; Bai, W. G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J. Biol. Chem., 2003, 278(48), 48030-48040.
[http://dx.doi.org/10.1074/jbc.M308430200] [PMID: 14506229]
[110]
Li, P.; Li, C.; Zhao, X.; Zhang, X.; Nicosia, S.V.; Bai, W. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. J. Biol. Chem., 2004, 279(24), 25260-25267.
[http://dx.doi.org/10.1074/jbc.M311052200] [PMID: 15075339]
[111]
Jiang, F.; Bao, J.; Li, P.; Nicosia, S.V.; Bai, W. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J. Biol. Chem., 2004, 279(51), 53213-53221.
[http://dx.doi.org/10.1074/jbc.M410395200] [PMID: 15485861]
[112]
Peehl, D.M.; Shinghal, R.; Nonn, L.; Seto, E.; Krishnan, A.V.; Brooks, J.D.; Feldman, D. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis. J. Steroid Biochem. Mol. Biol., 2004, 92(3), 131-141.
[http://dx.doi.org/10.1016/j.jsbmb.2004.07.003] [PMID: 15555907]
[113]
Lambert, J.R.; Kelly, J.A.; Shim, M.; Huffer, W.E.; Nordeen, S.K.; Baek, S.J.; Eling, T.E.; Lucia, M.S. Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J. Cell. Physiol., 2006, 208(3), 566-574.
[http://dx.doi.org/10.1002/jcp.20692] [PMID: 16741990]
[114]
Zhang, X.; Li, P.; Bao, J.; Nicosia, S.V.; Wang, H.; Enkemann, S.A.; Bai, W. Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis. J. Biol. Chem., 2005, 280(42), 35458-35468.
[http://dx.doi.org/10.1074/jbc.M506648200] [PMID: 16093247]
[115]
Winsløw, U.; Nordestgaard, B.; Afzal, S. High plasma 25á hydroxyvitamin D and high risk of non‐melanoma skin cancer: A Mendelian randomisation study of 97849 individuals. Br. J. Dermatol., 2018, 178(6), 1388-1395.
[PMID: 29143981]
[116]
Stepien, T.; Krupinski, R.; Sopinski, J.; Kuzdak, K.; Komorowski, J.; Lawnicka, H.; Stepien, H. Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch. Med. Res., 2010, 41(3), 190-194.
[http://dx.doi.org/10.1016/j.arcmed.2010.04.004] [PMID: 20682176]
[117]
Kim, J.R.; Kim, B.H.; Kim, S.M.; Oh, M.Y.; Kim, W.J.; Jeon, Y.K.; Kim, S.S.; Lee, B.J.; Kim, Y.K.; Kim, I.J. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid, 2014, 24(11), 1618-1624.
[http://dx.doi.org/10.1089/thy.2014.0090] [PMID: 25133449]
[118]
Emami, A.; Nazem, M.R.; Shekarriz, R.; Hedayati, M. Micronutrient status (calcium, zinc, vitamins D and E) in patients with medullary thyroid carcinoma: A cross-sectional study. Nutrition, 2017, 41, 86-89.
[http://dx.doi.org/10.1016/j.nut.2017.04.004] [PMID: 28760434]
[119]
Wong, H-L.; Seow, A.; Arakawa, K.; Lee, H-P.; Yu, M.C.; Ingles, S.A. Vitamin D receptor start codon polymorphism and colorectal cancer risk: Effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis, 2003, 24(6), 1091-1095.
[http://dx.doi.org/10.1093/carcin/bgg059] [PMID: 12807755]
[120]
Kadiyska, T.; Yakulov, T.; Kaneva, R.; Nedin, D.; Alexandrova, A.; Gegova, A.; Savov, A.; Mitev, V.; Kremensky, I. Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria. Int. J. Colorectal Dis., 2007, 22(4), 395-400.
[http://dx.doi.org/10.1007/s00384-006-0163-0] [PMID: 16788818]
[121]
Slattery, M.L.; Murtaugh, M.; Caan, B.; Ma, K.N.; Wolff, R.; Samowitz, W. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control, 2004, 15(9), 863-872.
[http://dx.doi.org/10.1007/s10552-004-1048-6] [PMID: 15577288]
[122]
Ramagopalan, S.V.; Heger, A.; Berlanga, A.J.; Maugeri, N.J.; Lincoln, M.R.; Burrell, A.; Handunnetthi, L.; Handel, A.E.; Disanto, G.; Orton, S-M.; Watson, C.T.; Morahan, J.M.; Giovannoni, G.; Ponting, C.P.; Ebers, G.C.; Knight, J.C. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res., 2010, 20(10), 1352-1360.
[http://dx.doi.org/10.1101/gr.107920.110] [PMID: 20736230]
[123]
Taylor, J.A.; Hirvonen, A.; Watson, M.; Pittman, G.; Mohler, J.L.; Bell, D.A. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res., 1996, 56(18), 4108-4110.
[PMID: 8797574]
[124]
Ditsch, N.; Toth, B.; Mayr, D.; Lenhard, M.; Gallwas, J.; Weissenbacher, T.; Dannecker, C.; Friese, K.; Jeschke, U. The association between vitamin D receptor expression and prolonged overall survival in breast cancer. J. Histochem. Cytochem., 2012, 60(2), 121-129.
[http://dx.doi.org/10.1369/0022155411429155] [PMID: 22108646]
[125]
Ahmed, J.H. Makonnen, E. Vitamin D Status and Association of VDR Genetic Polymorphism to Risk of Breast Cancer in Ethiopia. Nutrients, 2019, 11(2), 289.
[http://dx.doi.org/10.3390/nu11020289]
[126]
Köstner, K.; Denzer, N.; Müller, C.S.; Klein, R.; Tilgen, W.; Reichrath, J. The relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: A review of the literature. Anticancer Res., 2009, 29(9), 3511-3536.
[PMID: 19667145]
[127]
Vaughan-Shaw, P.G.; O’Sullivan, F.; Farrington, S.M.; Theodoratou, E.; Campbell, H.; Dunlop, M.G.; Zgaga, L. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br. J. Cancer, 2017, 116(8), 1092-1110.
[http://dx.doi.org/10.1038/bjc.2017.44] [PMID: 28301870]
[128]
Uitterlinden, A.G.; Fang, Y.; Van Meurs, J.B.; Pols, H.A.; Van Leeuwen, J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene, 2004, 338(2), 143-156.
[http://dx.doi.org/10.1016/j.gene.2004.05.014] [PMID: 15315818]
[129]
Gnagnarella, P.; Pasquali, E.; Serrano, D.; Raimondi, S.; Disalvatore, D.; Gandini, S. Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis. Carcinogenesis, 2014, 35(9), 1913-1919.
[http://dx.doi.org/10.1093/carcin/bgu150] [PMID: 25053622]
[130]
Raimondi, S.; Pasquali, E.; Gnagnarella, P.; Serrano, D.; Disalvatore, D.; Johansson, H.A.; Gandini, S. BsmI polymorphism of vitamin D receptor gene and cancer risk: A comprehensive meta-analysis. Mutat. Res., 2014, 769, 17-34.
[http://dx.doi.org/10.1016/j.mrfmmm.2014.06.001] [PMID: 25771722]
[131]
Lee, J.E. Circulating levels of vitamin D, vitamin D receptor polymorphisms, and colorectal adenoma: A meta-analysis. Nutr. Res. Pract., 2011, 5(5), 464-470.
[http://dx.doi.org/10.4162/nrp.2011.5.5.464] [PMID: 22125685]
[132]
Poynter, J.N.; Jacobs, E.T.; Figueiredo, J.C.; Lee, W.H.; Conti, D.V.; Campbell, P.T.; Levine, A.J.; Limburg, P.; Le Marchand, L.; Cotterchio, M. Genetic variation in the Vitamin D Receptor (VDR) and the vitamin D–binding protein (GC) and risk for colorectal cancer: Results from the colon cancer family registry. Cancer Epidemiol. Prev. Biomarkers, 2010, 19(2), 525.
[133]
Hibler, E.A.; Hu, C.; Jurutka, P.W.; Martinez, M.E.; Jacobs, E.T. Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol. Biomarkers Prev., 2012, 21(2), 368-375.
[http://dx.doi.org/10.1158/1055-9965.EPI-11-0916] [PMID: 22144504]
[134]
Kong, J.; Chen, X.; Wang, J.; Li, J.; Xu, F.; Gao, S.; Yu, H.; Qian, B. Genetic polymorphisms in the vitamin D pathway and non-small cell lung cancer survival. Pathol. Oncol. Res., 2020, 26(3), 1709-1715.
[135]
Holick, C.N.; Stanford, J.L.; Kwon, E.M.; Ostrander, E.A.; Nejentsev, S.; Peters, U. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer. Cancer Epidemiol. Biomarkers Prev., 2007, 16(10), 1990-1999.
[http://dx.doi.org/10.1158/1055-9965.EPI-07-0487] [PMID: 17932346]
[136]
Mahmoudi, T.; Karimi, K.; Arkani, M.; Farahani, H.; Nobakht, H.; Dabiri, R.; Asadi, A.; Vahedi, M.; Zali, M.R. Lack of associations between Vitamin D metabolism-related gene variants and risk of colorectal cancer. Asian Pac. J. Cancer Prev., 2014, 15(2), 957-961.
[http://dx.doi.org/10.7314/APJCP.2014.15.2.957] [PMID: 24568525]
[137]
Berger, M.D.; Stintzing, S.; Heinemann, V.; Cao, S.; Yang, D.; Sunakawa, Y.; Matsusaka, S.; Ning, Y.; Okazaki, S.; Miyamoto, Y.; Suenaga, M.; Schirripa, M.; Hanna, D.L.; Soni, S.; Puccini, A.; Zhang, W.; Cremolini, C.; Falcone, A.; Loupakis, F.; Lenz, H.J. A polymorphism within the vitamin D transporter gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab. Clin. Cancer Res., 2018, 24(4), 784-793.
[138]
Akiba, T.; Morikawa, T.; Odaka, M.; Nakada, T.; Kamiya, N.; Yamashita, M.; Yabe, M.; Inagaki, T.; Asano, H.; Mori, S.; Tsukamoto, Y.; Urashima, M. Vitamin D supplementation and survival of patients with non-small cell lung cancer: A randomized, double-blind, placebo-controlled trial. Clin. Cancer Res., 2018, 24(17), 4089-4097.
[139]
Arai, H.; Miyamoto, K.I.; Yoshida, M.; Yamamoto, H.; Taketani, Y.; Morita, K.; Kubota, M.; Yoshida, S.; Ikeda, M.; Watabe, F.; Kanemasa, Y.; Takeda, E. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J. Bone Miner. Res., 2001, 16(7), 1256-1264.
[http://dx.doi.org/10.1359/jbmr.2001.16.7.1256]
[140]
Karami, S.; Brennan, P.; Rosenberg, P.S.; Navratilova, M.; Mates, D.; Zaridze, D.; Janout, V.; Kollarova, H.; Bencko, V.; Matveev, V.; Szeszenia-Dabrowska, N.; Holcatova, I.; Yeager, M.; Chanock, S.; Menashe, I.; Rothman, N.; Chow, W.H.; Boffetta, P.; Moore, L.E. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS One, 2009, 4(9)e7013
[http://dx.doi.org/10.1371/journal.pone.0007013] [PMID: 19753122]
[141]
Afzal, S.; Brøndum-Jacobsen, P.; Bojesen, S.E.; Nordestgaard, B.G. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ, 2014, 349, g6330.
[http://dx.doi.org/10.1136/bmj.g6330] [PMID: 25406188]
[142]
Chandler, P.D.; Tobias, D.K.; Wang, L.; Smith-Warner, S.A.; Chasman, D.I.; Rose, L.; Giovannucci, E.L.; Buring, J.E.; Ridker, P.M.; Cook, N.R.; Manson, J.E.; Sesso, H.D. Association between Vitamin D genetic risk score and cancer risk in a large cohort of U.S. women. Nutrients, 2018, 10(1)E55
[http://dx.doi.org/10.3390/nu10010055] [PMID: 29315215]
[143]
Ong, J.S.; Gharahkhani, P.; An, J.; Law, M.H.; Whiteman, D.C.; Neale, R.E.; MacGregor, S. Vitamin D and overall cancer risk and cancer mortality: A Mendelian randomization study. Hum. Mol. Genet., 2018, 27(24), 4315-4322.
[http://dx.doi.org/10.1093/hmg/ddy307] [PMID: 30508204]
[144]
Orton, S.M.; Morris, A.P.; Herrera, B.M.; Ramagopalan, S.V.; Lincoln, M.R.; Chao, M.J.; Vieth, R.; Sadovnick, A.D.; Ebers, G.C. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr., 2008, 88(2), 441-447.
[http://dx.doi.org/10.1093/ajcn/88.2.441] [PMID: 18689381]
[145]
Wjst, M.; Altmüller, J.; Braig, C.; Bahnweg, M.; André, E. A genome-wide linkage scan for 25-OH-D(3) and 1,25-(OH)2-D3 serum levels in asthma families. J. Steroid Biochem. Mol. Biol., 2007, 103(3-5), 799-802.
[http://dx.doi.org/10.1016/j.jsbmb.2006.12.053] [PMID: 17236760]
[146]
Manolio, T.A.; Collins, F.S.; Cox, N.J.; Goldstein, D.B.; Hindorff, L.A.; Hunter, D.J.; McCarthy, M.I.; Ramos, E.M.; Cardon, L.R.; Chakravarti, A.; Cho, J.H.; Guttmacher, A.E.; Kong, A.; Kruglyak, L.; Mardis, E.; Rotimi, C.N.; Slatkin, M.; Valle, D.; Whittemore, A.S.; Boehnke, M.; Clark, A.G.; Eichler, E.E.; Gibson, G.; Haines, J.L.; Mackay, T.F.; McCarroll, S.A.; Visscher, P.M. Finding the missing heritability of complex diseases. Nature, 2009, 461(7265), 747-753.
[http://dx.doi.org/10.1038/nature08494] [PMID: 19812666]
[147]
Kazemian, E.; Akbari, M.E.; Moradi, N.; Gharibzadeh, S.; Mondul, A.M. Vitamin D receptor genetic variation and cancer biomarkers among breast cancer patients supplemented with vitamin D3: A single-arm non-randomized before and after trial. Nutrients, 2019, 11(6), 1264.
[http://dx.doi.org/10.3390/nu11061264]
[148]
Jjingo, D.; Conley, A.B.; Yi, S.V.; Lunyak, V.V.; Jordan, I.K. On the presence and role of human gene-body DNA methylation. Oncotarget, 2012, 3(4), 462-474.
[http://dx.doi.org/10.18632/oncotarget.497] [PMID: 22577155]
[149]
O’Brien, K.M.; Sandler, D.P.; Xu, Z.; Kinyamu, H.K.; Taylor, J.A.; Weinberg, C.R. Vitamin D DNA methylation, and breast cancer. Breast Cancer Res., 2018, 20(1), 70.
[http://dx.doi.org/10.1186/s13058-018-0994-y] [PMID: 29996894]
[150]
Chlebowski, R.T.; Johnson, K.C.; Kooperberg, C.; Pettinger, M.; Wactawski-Wende, J.; Rohan, T.; Rossouw, J.; Lane, D.; O’Sullivan, M.J.; Yasmeen, S.; Hiatt, R.A.; Shikany, J.M.; Vitolins, M.; Khandekar, J.; Hubbell, F.A. Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of breast cancer. J. Natl. Cancer Inst., 2008, 100(22), 1581-1591.
[http://dx.doi.org/10.1093/jnci/djn360] [PMID: 19001601]
[151]
Trivedi, D.; Doll, R.; Khaw, K. Effect of four monthly oral vitamin D3 (cholecalciferol) and mortality in men and women living in the community: randomised double blind controlled trial. BMJ, 2003, 326, 469-478.
[http://dx.doi.org/10.1136/bmj.326.7387.469] [PMID: 12609940]
[152]
Manson, J.E.; Cook, N.R.; Lee, I.M.; Christen, W.; Bassuk, S.S.; Mora, S.; Gibson, H.; Gordon, D.; Copeland, T.; D’Agostino, D.; Friedenberg, G.; Ridge, C.; Bubes, V.; Giovannucci, E.L.; Willett, W.C.; Buring, J.E.; Vitamin, D. VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N. Engl. J. Med., 2019, 380(1), 33-44.
[http://dx.doi.org/10.1056/NEJMoa1809944] [PMID: 30415629]
[153]
Scragg, R.; Khaw, K.T.; Toop, L.; Sluyter, J.; Lawes, C.M.M.; Waayer, D.; Giovannucci, E.; Camargo, C.A., Jr Monthly high-dose vitamin D supplementation and cancer risk: A post hoc analysis of the vitamin D assessment randomized clinical trial. JAMA Oncol., 2018, 4(11)e182178
[http://dx.doi.org/10.1001/jamaoncol.2018.2178] [PMID: 30027269]
[154]
Lappe, J.; Watson, P.; Travers-Gustafson, D.; Recker, R.; Garland, C.; Gorham, E.; Baggerly, K.; McDonnell, S.L. Effect of vitamin D and calcium supplementation on cancer incidence in older women: A randomized clinical trial. JAMA, 2017, 317(12), 1234-1243.
[http://dx.doi.org/10.1001/jama.2017.2115] [PMID: 28350929]
[155]
Chung, M.; Lee, J.; Terasawa, T.; Lau, J.; Trikalinos, T.A. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: An updated meta-analysis for the U.S. Preventive Services Task Force. Ann. Intern. Med., 2011, 155(12), 827-838.
[http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00005] [PMID: 22184690]
[156]
Goulão, B.; Stewart, F.; Ford, J.A.; MacLennan, G.; Avenell, A. Cancer and vitamin D supplementation: A systematic review and meta-analysis. Am. J. Clin. Nutr., 2018, 107(4), 652-663.
[http://dx.doi.org/10.1093/ajcn/nqx047] [PMID: 29635490]

Rights & Permissions Print Cite
Article Metrics
22
3
© 2024 Bentham Science Publishers | Privacy Policy